Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

ProstaTep

ProstaTep, 500 MBq/mL, solution for injection

Active ingredient

F18-fluorocholine

Disease area

Endocrinology, Oncology

Available in

ProstaTep in France

Product information

Sodium iodide (123I)

Sodium iodide (123I) CIS bio international 18.5 MBq/mL solution for injection

Active ingredient

I123-sodium

Disease area

Endocrinology

Available in

Sodium iodide (123I) in France

Product information

Sodium iodide (¹³¹I)

MONIYOT-131 Capsule T 37-7400 MBq hard capsule for therapeutic use

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) in Denmark

Product information
, 

Sodium iodide (¹³¹I) in Germany

Product information
, 

Sodium iodide (¹³¹I) in Greece

Product information

Sodium iodide (¹³¹I) in Romania

Product information

Sodium iodide (¹³¹I) – oral solution

MONIYOT-131 14.8–3700 MBq/mL oral solution

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) – oral solution in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Denmark

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Germany

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Greece

Product information

Sodium iodide (¹³¹I) – oral solution in Romania

Product information

Sodium Iodide I-123 Capsules

Sodium Iodide I-123 Capsules

Active ingredient

Sodium Iodide I-123

Disease area

Endocrinology

Available in

Sodium Iodide I-123 Capsules in United States

Product information

Sodium Iodide I-131 Capsules Therapeutic

Sodium Iodide (131I) Capsules T 37-7400 MBq/mL hard capsule

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I-131 Capsules Therapeutic in Austria

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Belgium

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Bosnia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Colombia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Costa Rica

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Czech Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Denmark

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Dominican Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Finland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in France

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Germany

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Hungary

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Ireland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Italy

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Mexico

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Netherlands

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Norway

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Peru

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Portugal

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Serbia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Slovakia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Spain

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Sweden

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Switzerland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Turkey

Product information

Sodium Iodide I-131 Capsules Therapeutic in United Kingdom

Product information

Sodium Iodide I123 Injection

Sodium iodide (123I) 37 MBq/mL solution for injection

Active ingredient

I123-sodium

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I123 Injection in Belgium

Product information
, 

Sodium Iodide I123 Injection in Czech Republic

Product information
, 

Sodium Iodide I123 Injection in Denmark

Product information
, 

Sodium Iodide I123 Injection in Finland

Product information
, 

Sodium Iodide I123 Injection in France

Product information
, 

Sodium Iodide I123 Injection in Germany

Product information
, 

Sodium Iodide I123 Injection in Hungary

Product information
, 

Sodium Iodide I123 Injection in Italy

Product information
, 

Sodium Iodide I123 Injection in Netherlands

Product information
, 

Sodium Iodide I123 Injection in Norway

Product information
, 

Sodium Iodide I123 Injection in Spain

Product information
, 

Sodium Iodide I123 Injection in Sweden

Product information
, 

Sodium Iodide I123 Injection in Switzerland

Product information

Sodium Iodide I123 Injection in United Kingdom

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Austria

Product information
, 

Technescan™ Sestamibi in Belgium

Product information
, 

Technescan™ Sestamibi in Bulgaria

Product information
, 

Technescan™ Sestamibi in Cyprus

Product information
, 

Technescan™ Sestamibi in Czech Republic

Product information
, 

Technescan™ Sestamibi in Denmark

Product information
, 

Technescan™ Sestamibi in Estonia

Product information
, 

Technescan™ Sestamibi in Finland

Product information
, 

Technescan™ Sestamibi in France

Product information
, 

Technescan™ Sestamibi in Germany

Product information
, 

Technescan™ Sestamibi in Greece

Product information
, 

Technescan™ Sestamibi in Hungary

Product information
, 

Technescan™ Sestamibi in International

Product information
, 

Technescan™ Sestamibi in Ireland

Product information
, 

Technescan™ Sestamibi in Italy

Product information
, 

Technescan™ Sestamibi in Latvia

Product information
, 

Technescan™ Sestamibi in Lithuania

Product information
, 

Technescan™ Sestamibi in Luxembourg

Product information
, 

Technescan™ Sestamibi in Netherlands

Product information
, 

Technescan™ Sestamibi in Norway

Product information
, 

Technescan™ Sestamibi in Portugal

Product information
, 

Technescan™ Sestamibi in Romania

Product information
, 

Technescan™ Sestamibi in Slovakia

Product information
, 

Technescan™ Sestamibi in Slovenia

Product information
, 

Technescan™ Sestamibi in Spain

Product information
, 

Technescan™ Sestamibi in Sweden

Product information
, 

Technescan™ Sestamibi in Switzerland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Technetium-99m generator

MONTEK 10-40 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Technetium-99m generator in Austria

Product information
, 

Technetium-99m generator in Belgium

Product information
, 

Technetium-99m generator in Bulgaria

Product information
, 

Technetium-99m generator in Denmark

Product information
, 

Technetium-99m generator in France

Product information
, 

Technetium-99m generator in Germany

Product information
, 

Technetium-99m generator in Greece

Product information
, 

Technetium-99m generator in Hungary

Product information
, 

Technetium-99m generator in Italy

Product information
, 

Technetium-99m generator in Netherlands

Product information
, 

Technetium-99m generator in Poland

Product information
, 

Technetium-99m generator in Portugal

Product information
, 

Technetium-99m generator in Romania

Product information

Technetium-99m generator in Spain

Product information

Thallium 201TI

Thallium (201Tl) chloride CIS bio international 37 MBq/mL solution for injection (Tl-201-S-1)

Active ingredient

Tl201-chloride

Disease area

Cardiology, Endocrinology, Musculoskeletal, Oncology

Available in
, 

Thallium 201TI in Austria

Product information
, 

Thallium 201TI in Belgium

Product information
, 

Thallium 201TI in France

Product information
, 

Thallium 201TI in Greece

Product information
, 

Thallium 201TI in International

Product information
, 

Thallium 201TI in Luxembourg

Product information
, 

Thallium 201TI in Mexico

Product information
, 

Thallium 201TI in Netherlands

Product information
, 

Thallium 201TI in Portugal

Product information
, 

Thallium 201TI in South America

Product information
, 

Thallium 201TI in Spain

Product information

Thallium 201TI in Taiwan

Product information

Thallous Chloride Tl 201 Injection

Thallous Chloride Tl 201 Injection

Active ingredient

Tl201-Chloride

Disease area

Cardiology, Endocrinology

Available in
, 

Thallous Chloride Tl 201 Injection in Austria

Product information
, 

Thallous Chloride Tl 201 Injection in Belgium

Product information
, 

Thallous Chloride Tl 201 Injection in Czech Republic

Product information
, 

Thallous Chloride Tl 201 Injection in Denmark

Product information
, 

Thallous Chloride Tl 201 Injection in Finland

Product information
, 

Thallous Chloride Tl 201 Injection in France

Product information
, 

Thallous Chloride Tl 201 Injection in Germany

Product information
, 

Thallous Chloride Tl 201 Injection in Hungary

Product information
, 

Thallous Chloride Tl 201 Injection in Ireland

Product information
, 

Thallous Chloride Tl 201 Injection in Italy

Product information
, 

Thallous Chloride Tl 201 Injection in Netherlands

Product information
, 

Thallous Chloride Tl 201 Injection in Portugal

Product information
, 

Thallous Chloride Tl 201 Injection in Singapore

Product information
, 

Thallous Chloride Tl 201 Injection in Slovakia

Product information
, 

Thallous Chloride Tl 201 Injection in Spain

Product information
, 

Thallous Chloride Tl 201 Injection in Sweden

Product information
, 

Thallous Chloride Tl 201 Injection in Switzerland

Product information
, 

Thallous Chloride Tl 201 Injection in United Kingdom

Product information

Thallous Chloride Tl 201 Injection in United States

Product information

Ultra Technekow™ FM

Ultra-Technekow FM 2.15-43.00 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Ultra Technekow™ FM in Austria

Product information
, 

Ultra Technekow™ FM in Belgium

Product information
, 

Ultra Technekow™ FM in Bosnia

Product information
, 

Ultra Technekow™ FM in Colombia

Product information
, 

Ultra Technekow™ FM in Costa Rica

Product information
, 

Ultra Technekow™ FM in Cyprus

Product information
, 

Ultra Technekow™ FM in Czech Republic

Product information
, 

Ultra Technekow™ FM in Denmark

Product information
, 

Ultra Technekow™ FM in Dominican Republic

Product information
, 

Ultra Technekow™ FM in Finland

Product information
, 

Ultra Technekow™ FM in France

Product information
, 

Ultra Technekow™ FM in Germany

Product information
, 

Ultra Technekow™ FM in Greece

Product information
, 

Ultra Technekow™ FM in Hong Kong

Product information
, 

Ultra Technekow™ FM in Hungary

Product information
, 

Ultra Technekow™ FM in India

Product information
, 

Ultra Technekow™ FM in Ireland

Product information
, 

Ultra Technekow™ FM in Italy

Product information
, 

Ultra Technekow™ FM in Luxembourg

Product information
, 

Ultra Technekow™ FM in Malaysia

Product information
, 

Ultra Technekow™ FM in Moldova

Product information
, 

Ultra Technekow™ FM in Netherlands

Product information
, 

Ultra Technekow™ FM in Norway

Product information
, 

Ultra Technekow™ FM in Peru

Product information
, 

Ultra Technekow™ FM in Poland

Product information
, 

Ultra Technekow™ FM in Portugal

Product information
, 

Ultra Technekow™ FM in Republic of Korea

Product information
, 

Ultra Technekow™ FM in Romania

Product information
, 

Ultra Technekow™ FM in Serbia

Product information
, 

Ultra Technekow™ FM in Singapore

Product information
, 

Ultra Technekow™ FM in Slovakia

Product information
, 

Ultra Technekow™ FM in Spain

Product information
, 

Ultra Technekow™ FM in Sweden

Product information
, 

Ultra Technekow™ FM in Switzerland

Product information
, 

Ultra Technekow™ FM in Turkey

Product information

Ultra Technekow™ FM in United Kingdom

Product information

Ultra-Technekow™ V4

(technetium Tc 99m generator)

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators, Urology